Job title: Senior Director Regulatory Affairs, CMC
Dr. Qing-Hong Dai currently serves as Senior Director of Regulatory Affairs – CMC at Adverum Biotechnologies. She brings diverse experience in global regulatory CMC and drug development in the areas of ophthalmology, oncology, hematology and rare diseases. She is responsible for developing and implementing CMC regulatory strategies for INDs, CTAs, and market applications throughout the clinical and commercial lifecycle management. Qing-Hong earned her Ph.D. in Biophysical chemistry from Rutgers University at New Brunswick, and holds a B.S. in Chemistry from Peking University.